Saturday, July 12, 2014





Pfizer animal health IPO could raise more than $2B


February 20. 2013 2:39AM
Story Tools
PrintPrint | E-MailEMail | SaveSave | Hear Generate QR Code QR
Send to Kindle


(AP) Drugmaker Pfizer Inc., which is spinning off its animal health business through an initial public offering, intends to sell 86.1 million shares of common stock.


New York-based Pfizer estimates the price for shares of the unit, called Zoetis (zoh-EHT'-ihs) Inc., at $22 to $25. At those prices, the IPO would raise $1.89 billion to $2.15 billion.


The business, which sells vaccines and medicines for pets and farm animals, had 2011 revenue of $4.2 billion.


That makes it the world's largest animal health business, according to a prospectus Pfizer filed with the Securities and Exchange Commission. It notes Zoetis products are sold in more than 120 countries, in five major product categories.


The unit's spinoff is part of efforts by Pfizer CEO Ian Read to revamp the world's largest drugmaker.


Associated Press


Comments
comments powered by Disqus Commenting Guidelines
Poll
Mortgage Minute


Search for New & Used Cars

Make 
Model
 
Used New All
 

Search Times Leader Classifieds to find just the home you want!

Search Times Leader Classifieds to find just what you need!

Search Pet Classifieds
Dogs Cats Other Animals



Social Media/RSS
Times Leader on Twitter
Times Leader on Youtube
Times Leader on Google+
The Times Leader on Tumblr
The Times Leader on Pinterest
Times Leader RSS Feeds